Serum levels of VCANM were also found to decrease in patients with exacerbated chronic obstructive pulmonary disease (COPD) compared to those in the recovery phase [211], when total versican levels in the lung are known to rise [214], suggesting that versican accumulation may be driven by reduced proteolysis by MMPs. Here, VCAN is linked to chronic obstructive pulmonary disease.